Celon Pharma SA's total assets for Q1 2025 were zł522.59M, a decrease of -3.90% from the previous quarter. DE:8RP total liabilities were zł103.06M for the fiscal quarter, a 4.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.